Implantica Expands Manufacturing of RefluxStop Device to Meet Anticipated US Demand
Implantica AG, a medtech company pioneering advanced technology inside the body, has unveiled its strategy to manufacture 10,000 RefluxStop devices in preparation for substantial demand from the United States, following FDA pre-market approval.
FDA Pre-market Approval | 12/09/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy